Beijing CAS Microneedle Technology, Ltd.

Beijing CAS Microneedle Technology, Ltd. was registered in May 2018 and is a technology achievement transformation enterprise founded by Dr. Gao Yunhua's research team. It mainly engages in the research and development, production, and sales of polymer microneedle technology and innovative transdermal technology. Beijing CAS Microneedle Technology, Ltd (referred to as "CASMN") is located at the Biomedical Base in Daxing District, Beijing. It is a pilot research and development base covering an area of over 2000 square meters, mainly engaged in the application research and technical services of microneedle technology and transdermal technology in the fields of pharmaceutical preparations, medical devices, and cosmetics, and has the ability to provide CRO project research and development services, We have a pilot scale production capacity of 20 million stickers per year. In October 2019, the subsidiary Chongqing  Microneedle Technology Ltd. (referred to as "Chongqing CAS Company") was registered in Changshou District, Chongqing. It covers an area of over 8000 square meters and is mainly engaged in the research and development and production of innovative transdermal technology products in the field of medical aesthetics. It has built a GMP automated production line with a production capacity of 150 million patches per year, and was officially put into operation in 2021. CAS Microneedle is committed to the development and production service platform construction of internationally advanced and domestically first-class polymer microneedle formulations and innovative transdermal technologies, aiming to provide advanced microneedle transdermal technology solutions for customers in the field of big health.

Company Honor
The construction of the Beijing Comprehensive R&D Base has been successfully accepted and put into use; Completion of Postdoctoral Workstation Construction
Class II medical devices have been put into production. 
In 2023, The Pharmaceutical Research and Development project has been initiated, and Class III medical device projects have also been launched.
Series A financing Alibaba Jiangsu Zijin Shanghai Haixiang He Yongjun Beijing Jinke Huiyu; Construction of Class II and III medical device systems in Beijing Daxing Base; Construction of drug research and development platform
In January 2021, Chongqing CAS Microneedle Base obtained a cosmetics production license; 
Cosmetics production base put into operation officially in Jan of 2021.
Pre A round of financing, CAS Yinghui Fund; Awarded as a national high-tech enterprise in July 2020; Construction of Chongqing Microneedle Technology Ltd. from December 2020
Starting construction of Beijing Daxing Pilot Base in February 2019; Beijing Daxing Base obtained a Class I medical device production license On November 2019,; Product sold by distributor agent officially at 2019-11
Established CAS MicroNeedle Ten Million Angel Round Financing in May 2018, Chinese Academy of Sciences Venture Capital Zhongke Chuangxing
Beijing CAS Microneedle Technology Established in 2018
Located in the biopharmaceutical industry base of Daxing District, with a registered capital of 20,164,609 yuan,Registered on May 23, 2018  
Completed the amplification process of the microneedle laboratory project at the Institute of Physics and Chemistry, Chinese Academy of Sciences in 2017
Dissolvable Microneedle Small Batch R&D Process Completed in 2015
National 863 Plan Initiates Research and Development in 2003.

Contact us:010-89287035  4006-909-698

Business cooperation  


Address of Beijing:Building 21, phase 2, zhongguancun medical equipment park,NO.69 Qingfeng West Road, Daxing District, Beijing

Address of Chongqing:No. 2 Kangfu Road, Gelan Town, Changshou District, Chongqing